This article is more than 5 years old. Information may no longer be current.
AKF names Stanford University fellow as scientist in nephrology fellow
Click Here to Manage Email Alerts
Kathrine M. Wang, MD, a second-year nephrology fellow at Stanford University, has been named the American Kidney Fund Clinical Scientist in Nephrology fellow for 2018 and 2019.
The Clinical Scientist in Nephrology grant from American Kidney Fund (AKF) will fund her research to study the effects of intensive treatment of hypertension in patients with CKD and factors associated with the inability to achieve lower systolic blood pressure targets.
“My research as an AKF Clinical Scientist in Nephrology fellow will provide valuable insights into patient subgroups that may pose significant challenges in terms of achieving more intensive blood pressure targets,” Wang said in a press release from the AKF.
The Clinical Scientist in Nephrology program strives to improve the quality of care provided to kidney patients and promotes clinical research in nephrology. It enhances the training of nephrologists who want to pursue an academic career and whose primary professional commitment is to scholarship in the provision of patient care.
Wangs research includes a secondary analysis of data collected in the Systolic Blood Pressure Intervention Trial (SPRINT). The study demonstrated patients with hypertension who were treated to achieve a lower systolic blood pressure than standard targets had a reduced risk for fatal and non-fatal cardiovascular events, and a lower risk for death overall. Wang will have access to newly released data from SPRINT to help her identify determinants and consequences of being unable to reach the lower, more intensive systolic blood pressure target and how this is related to cardiovascular and non-cardiovascular outcomes in patients with kidney diseases.
Reference: